bifidobacterium longum strain BB536
Identification
| Name | bifidobacterium longum strain BB536 |
Regulatory
| FDA/DG SANTE Petitions, Reviews, Notices | GRN 268 |
Physical Properties
| Food Chemicals Codex Listed | No |
No sensory data available
Safety Information
| Oral/Parenteral Toxicity | Not determined |
| Dermal Toxicity | Not determined |
| Inhalation Toxicity | Not determined |
GHS Classification
['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']
Safety in Use
| Category | food additive |
| Recommendation for bifidobacterium longum strain BB536 usage levels up to | not for fragrance use. |
| Recommendation for bifidobacterium longum strain BB536 flavor usage levels up to | not for flavor use. |
No supplier data available
Potential Uses
Natural Occurrence
Synonyms
bifidobacterium longum strain BB536
PubMed:
Effect of the oral intake of yogurt containing Bifidobacterium longum BB536 on the cell numbers of enterotoxigenic Bacteroides fragilis in microbiota.
PubMed:
Effect of administration of bifidobacteria on intestinal microbiota in low-birth-weight infants and transition of administered bifidobacteria: a comparison between one-species and three-species administration.
PubMed:
Cross-feeding between Bifidobacterium longum BB536 and acetate-converting, butyrate-producing colon bacteria during growth on oligofructose.
PubMed:
Effect of probiotic Bifidobacterium longum BB536 [corrected] in relieving clinical symptoms and modulating plasma cytokine levels of Japanese cedar pollinosis during the pollen season. A randomized double-blind, placebo-controlled trial.
PubMed:
Influence of Bifidobacterium longum BB536 intake on faecal microbiota in individuals with Japanese cedar pollinosis during the pollen season.
PubMed:
Effect of production conditions on the stability of a human bifidobacterial species Bifidobacterium longum in yogurt.
PubMed:
An immunostimulatory DNA sequence from a probiotic strain of Bifidobacterium longum inhibits IgE production in vitro.
PubMed:
Oral administration of Bifidobacterium longum prevents gut-derived Pseudomonas aeruginosa sepsis in mice.
PubMed:
Improved viability of bifidobacteria in fermented milk by cocultivation with Lactococcus lactis subspecies lactis.
PubMed:
Immunostimulatory oligodeoxynucleotide from Bifidobacterium longum suppresses Th2 immune responses in a murine model.
PubMed:
Safety evaluation of probiotic bifidobacteria by analysis of mucin degradation activity and translocation ability.
PubMed:
In vitro kinetic analysis of oligofructose consumption by Bacteroides and Bifidobacterium spp. indicates different degradation mechanisms.
PubMed:
Characterization of fructose 6 phosphate phosphoketolases purified from Bifidobacterium species.
PubMed:
Fluctuation of fecal microbiota in individuals with Japanese cedar pollinosis during the pollen season and influence of probiotic intake.
PubMed:
Probiotics in the treatment of Japanese cedar pollinosis: a double-blind placebo-controlled trial.
PubMed:
In vitro Th1 cytokine-independent Th2 suppressive effects of bifidobacteria.
PubMed:
Kinetic analysis of bifidobacterial metabolism reveals a minor role for succinic acid in the regeneration of NAD+ through its growth-associated production.